Page 2 - Novartis India

Novartis India appoints Sanjay Murdeshwar as MD and vice chairman

Pharma firm Novartis India Saturday announced the appointment of Sanjay Murdeshwar as vice chairman and managing director of the company. "..based on recommendation of the Nomination and Remuneration Committee of the Board, the Board of Directors of Novartis lndia Ltd at their meeting held today, have approved the appointment of Sanjay Murdeshwar as Vice Chairman & Managing Director of the Company effective June 15, 2019, subject to the approval of Shareholders and Central Government," a company statement said. Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country. He is also managing director of Novartis Healthcare Private Ltd. Murdeshwar comes with more than 20 years of experience in the healthcare industry which includes varied roles in the pharmaceuticals and consumer health businesses, it added.

Novartis India MD Milan Paleja to step down with effect from May 31

The company's board has requested the nomination and remuneration committee to identify and recommend a suitable successor for the role

Novartis India board clears share buyback worth Rs 231 cr

Shares of Novartis India were trading 6.85% down at Rs 635.85 apiece on BSE

Novartis India slips 8% as buyback price disappoints

The board approved share buyback at a price of Rs 670 per share, against Friday's close of Rs 683 on BSE.

Novartis India surges 7% as board mulls share buyback

So far in 2017, the stock under-performed the market by falling 24% as compared to 22% rise in the S&P BSE Sensex till Wednesday.

Novartis India Q1 net at Rs 19 crore

The company's shares were trading at Rs 718 per scrip on BSE, up 1.90%

Novartis India dips after board approves share buyback

The stock dipped 13% to Rs 720 after the board approved the buyback of shares at a price of Rs 760 through tender offer.

Novartis India surges on share buyback plans

The stock surged 15% to Rs 818 on the BSE in early morning trade.